Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Follow-Up Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis

NCT03347110 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT03347110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03347110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Follow-Up Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis
Lead sponsor
UCB Biopharma SRL
Phase
Phase 2
Overall status
Completed
Start date
November 22, 2017
Completion date
October 29, 2020
Enrollment
184 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis